Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03676738 · ClinicalTrials.gov registry record
Cohort Study of Risk Factors for Postoperative Cognitive Decline
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 125
- Enrollment target
NCT03676738 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 125 participants.
The verdict
NCT03676738 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Presently, the role of either genetic factors or biological sex in the development of postoperative cognitive dysfunction (POCD) is unknown. There is a critical need to determine which individuals are at high-risk for developing POCD by virtue of biological sex or genetic predisposition. The knowledge gained in the described research has the potential to shed light on mechanistic pathways, a necessary next step in order to ultimately identify therapeutic strategies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2022-05-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03676738
The ClinicalTrials.gov registry entry for NCT03676738 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03676738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03676738 about?
NCT03676738 is a clinical study titled "Cohort Study of Risk Factors for Postoperative Cognitive Decline". Presently, the role of either genetic factors or biological sex in the development of postoperative cognitive dysfunction (POCD) is unknown. There is a critical need to determine which individuals are at high-risk for developing POCD by virtue of biological sex or genetic predisposition. The knowled...
What is the current status of trial NCT03676738?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2018-03-26. Estimated completion is 2022-05-20.
Who is sponsoring clinical trial NCT03676738?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.